The telltale scan: APOE ε4 in multiple sclerosis

Lancet Neurology

Volumn 3, Issue 6, 2004, Pages 331-

  Masterman, Thomas ^a   Hillert, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; BRAIN SCINTISCANNING; DIAGNOSTIC APPROACH ROUTE; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SHORT SURVEY;

EID: 2442593505     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(04)00763-X     Document Type: Letter

References (5)

1. Enzinger C, Ropele S, Smith S, et al. Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-∈4. Ann Neurol. 55:2004;563-569
2. Masterman T, Zhang Z, Hellgren D, et al. APOE genotypes and disease severity in multiple sclerosis. Mult Scler. 8:2002;98-103
3. Fisher E, Rudick RA, Simon JH, et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology. 59:2002;1412-1420
4. Fazekas F, Strasser-Fuchs S, Kollegger H, et al. Apolipoprotein E ∈4 is associated with rapid progression of multiple sclerosis. Neurology. 57:2001;853-857
5. Fazekas F, Strasser-Fuchs S, Schmidt H, et al. Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis. J Neurol Neurosurg Psychiatry. 69:2000;25-28